文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

超低容量通气(≤3 ml/kg)联合体外二氧化碳清除(ECCO2R)在急性呼吸衰竭患者中的可行性与安全性

Feasibility and safety of ultra-low volume ventilation (≤ 3 ml/kg) combined with extra corporeal carbon dioxide removal (ECCO2R) in acute respiratory failure patients.
PubMed 文献 · Crit Care · 2024-12-27
一句话结论在急性呼吸衰竭患者中,ECCO2R辅助下超低容量通气(Vt≤3 ml/kg PBW)在45次治疗中仅18次(40.0%)成功,较高血流量与成功相关(校正OR每增加100 ml/min为1.51)。

本研究为前瞻性队列的回顾性分析,纳入41例急性呼吸衰竭患者共45次ECCO2R治疗,评估ECCO2R辅助下实现超低容量通气(Vt≤3 ml/kg PBW)的可行性。主要终点为ECCO2R启动后24小时成功维持Vt≤3 ml/kg PBW至少12小时的治疗比例,结果为40.0%(18/45次,CI 25.3-54.6%)。24小时时失败组Vt为4.1 [3.8-4.5] ml/kg PBW,成功组为2.1 [1.9-2.5] ml/kg PBW(p<0.001)。多因素分析显示血流量与超低容量通气成功显著相关(每增加100 ml/min,校正OR 1.51,95%CI 1.21-1.90,p=0.0003)。

要点

  • ECCO2R辅助下超低容量通气(Vt≤3 ml/kg PBW)在24小时成功维持至少12小时的比例为40.0%(18/45次,CI 25.3-54.6%)。
  • 24小时时失败组Vt为4.1 [3.8-4.5] ml/kg PBW,成功组为2.1 [1.9-2.5] ml/kg PBW(p<0.001)。
  • 多因素分析显示较高血流量与超低容量通气成功独立相关(每增加100 ml/min,校正OR 1.51,95%CI 1.21-1.90,p=0.0003)。
  • 研究为前瞻性队列的回顾性分析,共41例患者45次ECCO2R治疗,需注意其回顾性设计限制。

适用人群与场景

  • 急性呼吸衰竭患者,接受高或低血流量静脉-静脉ECCO2R装置治疗。

诊断标准与关键阈值

  • 超低容量通气成功定义为ECCO2R启动后24小时时Vt≤3 ml/kg PBW并至少维持12小时。

研究设计与关键结果

  • 研究类型:前瞻性队列的回顾性分析;样本量:41例患者共45次ECCO2R治疗。
  • 主要终点:ECCO2R启动后24小时成功实现Vt≤3 ml/kg PBW至少12小时的比例为40.0%(18/45次,CI 25.3-54.6%)。
  • 24小时Vt:失败组4.1 [3.8-4.5] ml/kg PBW vs 成功组2.1 [1.9-2.5] ml/kg PBW(p<0.001)。
  • 多因素分析:血流量每增加100 ml/min,超低容量通气成功的校正OR为1.51(95%CI 1.21-1.90,p=0.0003)。
  • 次要终点包括呼吸变量、不良事件发生率和结局,摘要未报告具体数据。

证据类型、等级与局限

  • 证据类型:前瞻性队列的回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为超低容量通气(≤3 ml/kg PBW)在ECCO2R辅助下可行,45次治疗中18次成功。
  • 作者认为较高血流量与超低容量通气成功相关。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Ultra-protective ventilation is the combination of low airway pressures and tidal volume (Vt) combined with extra corporeal carbon dioxide removal (ECCO2R). A recent large study showed no benefit of ultra-protective ventilation compared to standard ventilation in ARDS (Acute Respiratory Distress Syndrome) patients. However, the reduction in Vt failed to achieve the objective of less than or equal to 3 ml/kg predicted body weight (PBW). The main objective of our study was to assess the feasibility of the ultra-low volume ventilation (Vt ≤ 3 ml/kg PBW) facilitated by ECCO2R in acute respiratory failure patients.

METHODS: Retrospective analysis of a prospective cohort of patients with either high or low blood flow veno-venous ECCO2R devices. A session was defined as a treatment of ECCO2R from the start to the removal of the device (one patient could have one more than one session). Primary endpoint was the proportion of sessions during which a Vt less or equal to 3 ml/kg PBW at 24 h after the start of ECCO2R was successfully achieved for at least 12 h. Secondary endpoints were respiratory variables, rate of adverse events and outcomes.

RESULTS: Forty-five ECCO2R sessions were recorded among 41 patients. Ultra-low volume ventilation (tidal volume ≤ 3 ml/kg PBW, success group) was successfully achieved at 24 h in 40.0% sessions (18 out of 45 sessions, confidence interval 25.3-54.6%). At 24 h, tidal volume in the failure group was 4.1 [3.8-4.5] ml/kg PBW compared to 2.1 [1.9-2.5] in the success group (p < 0.001). After multivariate analysis, blood flow rate was significantly associated with success of ultra-low volume ventilation (adjusted OR per 100 ml/min increase 1.51 (95%CI 1.21-1.90, p = 0.0003).

CONCLUSION: Ultra-low volume ventilation (≤ 3 ml/kg PBW) was feasible in 18 out of 45 sessions. Higher blood flow rates were associated with the success of ultra-low volume ventilation.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Monet C, Renault T, Aarab Y, et al. Feasibility and safety of ultra-low volume ventilation (≤ 3 ml/kg) combined with extra corporeal carbon dioxide removal (ECCO2R) in acute respiratory failure patients. Crit Care. 2024. PMID: 39731126. doi:10.1186/s13054-024-05168-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。